At a glance
ClinicalIndex Comparison RecordN/ACompleted· 82 enrolled
Drug / intervention
Hypertonic saline +1 moredrug
Likely dose
Hypertonic saline 0.25 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Controlled Trial to Evaluate Efficacy of Nebulized Hypertonic Saline vs. Normal Saline in the Treatment of Hospitalized Children With Bronchiolitis
In Brief
A clinical study evaluating Hypertonic saline and Normal saline for Bronchiolitis. Completed, enrolled 82 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the efficacy of hypertonic saline vs. normal saline in the treatment of infants hospitalized for bronchiolitis, regarding length of hospital stay, oxygen requirements and clinical outcome.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBronchiolitis
CountriesArgentina
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 2010
Enrollment StartDec 2010
Primary CompletionOct 2011
Study CompletionMay 2012
TodayJul 2026
First PostedNov 11, 2010
Enrollment StartDec 1, 2010
Primary CompletionOct 1, 2011
Study CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 15.6 years ago
Interventions
Hypertonic salinedrug
3 cc nebulized hypertonic saline + albuterol 0.25 mg/kg/day, four times a day (QID), 5 days
Normal salinedrug
3 cc nebulized normal saline + albuterol 0.25 mg/kg/day, four times a day (QID), 5 days